Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,031 | 183 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $755.47 | 72 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $431.87 | 15 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $307.94 | 18 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $226.32 | 13 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $214.50 | 10 | $0 (2024) |
| Alkermes, Inc. | $213.24 | 10 | $0 (2024) |
| ITI, Inc. | $194.40 | 9 | $0 (2023) |
| Axsome Therapeutics, Inc. | $186.58 | 9 | $0 (2024) |
| Lundbeck LLC | $121.48 | 6 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $120.69 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $748.81 | 39 | ABBVIE INC. ($215.27) |
| 2023 | $828.84 | 55 | ABBVIE INC. ($242.78) |
| 2022 | $1,042 | 59 | Janssen Pharmaceuticals, Inc ($249.63) |
| 2021 | $410.63 | 30 | AbbVie Inc. ($157.24) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.12 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: Psychology/Psychiatric | ||||||
| 07/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Neuroscience | ||||||
| 06/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Central Nervous System | ||||||
| 06/03/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: ANTI-ANXIETY | ||||||
| 05/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Central Nervous System | ||||||
| 04/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.05 | General |
| Category: PSYCHIATRY | ||||||
| 04/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 60 | 255 | $38,430 | $14,774 |
| 2022 | 4 | 136 | 248 | $36,664 | $16,161 |
| 2021 | 2 | 47 | 74 | $9,350 | $4,975 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 116 | $18,834 | $8,106 | 43.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 25 | 126 | $15,954 | $5,080 | 31.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 13 | 13 | $3,642 | $1,588 | 43.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 71 | $11,192 | $5,287 | 47.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 40 | 40 | $10,483 | $4,739 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 76 | $7,282 | $3,446 | 47.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 22 | 61 | $7,707 | $2,688 | 34.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 58 | $5,510 | $3,099 | 56.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 16 | 16 | $3,840 | $1,876 | 48.9% |
About Jennifer Rawls, APRN
Jennifer Rawls, APRN is a Psychiatric/Mental Health healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2021. The National Provider Identifier (NPI) number assigned to this provider is 1831770981.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Rawls, APRN has received a total of $3,031 in payments from pharmaceutical and medical device companies, with $748.81 received in 2024. These payments were reported across 183 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,031).
As a Medicare-enrolled provider, Rawls has provided services to 243 Medicare beneficiaries, totaling 577 services with total Medicare billing of $35,911. Data is available for 3 years (2021–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Little Rock, AR
- Active Since 04/20/2021
- Last Updated 06/04/2021
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1831770981
Products in Payments
- VRAYLAR (Drug) $706.34
- CAPLYTA (Drug) $315.09
- INGREZZA (Drug) $307.94
- REXULTI (Drug) $297.18
- SPRAVATO (Drug) $273.95
- Auvelity (Drug) $170.62
- AUSTEDO (Drug) $157.92
- INVEGA SUSTENNA (Drug) $157.92
- LYBALVI (Drug) $141.47
- ARISTADA (Drug) $71.77
- Austedo XR (Drug) $68.40
- HETLIOZ (Drug) $48.62
- TRINTELLIX (Drug) $45.79
- QULIPTA (Drug) $43.82
- ABILIFY ASIMTUFII (Drug) $38.80
- NEUROSTAR TMS THERAPY SYSTEM (Device) $31.95
- KAPSPARGO (Drug) $30.33
- LOREEV XR (Drug) $21.97
- Dyanavel XR (Drug) $20.04
- QUVIVIQ (Drug) $17.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Little Rock
Cara Meckfessel, Aprn, APRN
Psychiatric/Mental Health — Payments: $7,199
Michelle Head
Psychiatric/Mental Health — Payments: $5,551
Sara Jones, Phd, Aprn, Pmhnp-Bc, PHD, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $4,663
Chloe Ward, Aprn, APRN
Psychiatric/Mental Health — Payments: $4,251
Ashley Taylor, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $2,381
Kizzie Houston
Psychiatric/Mental Health — Payments: $2,250